Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis
Volker Vielhauer, … , George Stavrakis, Tanya N. Mayadas
Volker Vielhauer, … , George Stavrakis, Tanya N. Mayadas
Published May 2, 2005
Citation Information: J Clin Invest. 2005;115(5):1199-1209. https://doi.org/10.1172/JCI23348.
View: Text | PDF
Categories: Article Nephrology

Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis

  • Text
  • PDF
Abstract

TNF is essential for the development of glomerulonephritis, an immune-mediated disorder that is a major cause of renal failure worldwide. However, TNF has proinflammatory and immunosuppressive properties that may segregate at the level of the 2 TNF receptors (TNFRs), TNFR1 and TNFR2. TNFR1-deficient mice subjected to immune complex–mediated glomerulonephritis developed less proteinuria and glomerular injury, and fewer renal leukocyte infiltrates at early time points after disease induction, and this was associated with a reduced systemic immune response to nephrotoxic rabbit IgG. However, proteinuria and renal pathology were similar to those in wild-type controls at later time points, when lack of TNFR1 resulted in excessive renal T cell accumulation and an associated reduction in apoptosis of these cells. In sharp contrast, TNFR2-deficient mice were completely protected from glomerulonephritis at all time points, despite an intact systemic immune response. TNFR2 was induced on glomerular endothelial cells of nephritic kidneys, and TNFR2 expression on intrinsic cells, but not leukocytes, was essential for glomerulonephritis and glomerular complement deposition. Thus, TNFR1 promotes systemic immune responses and renal T cell death, while intrinsic cell TNFR2 plays a critical role in complement-dependent tissue injury. Therefore, therapeutic blockade specifically of TNFR2 may be a promising strategy in the treatment of immune-mediated glomerulonephritis.

Authors

Volker Vielhauer, George Stavrakis, Tanya N. Mayadas

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Flow cytometric analysis of peripheral and renal leukocyte subsets isola...
Flow cytometric analysis of peripheral and renal leukocyte subsets isolated from nephritic mice. Whole-blood and single-cell suspensions obtained from spleen and nephritic kidneys of wild-type mice at day 21 were stained for (A) TNFR1 or (C) TNFR2 and CD3ε, αβ TCR, and γδ TCR or CD3ε and F4/80. After gating on CD3+ αβ TCR+, CD3+ γδ TCR+, and CD3– F4/80+ cells, the fraction of TNFR-positive cells was determined in comparison to staining with the isotype control antibody (Table 3). Representative histograms for staining of each cell population in the peripheral blood and kidney are shown in comparison to those for staining of the isotype control antibody (shaded histograms). (B) The proportion of apoptotic αβ T cells in spleen, lymph nodes, and kidneys of wild-type and TNFR1-deficient mice was determined after staining for annexin V, CD3ε, and αβ TCR. Dead cells were excluded after propidium iodide staining. Representative dot plots of 2 independent experiments are shown, and the fraction of apoptotic αβ T cells is indicated in the upper-right of the plots.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts